LAURIE TAYLOR: Open Payments
NPI 1346553435 · EXTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 65 payments from 18 companies in 2025. Trend: 2023 $236 · 2024 $689 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $202 |
| ABBVIE INC. | 10 | $176 |
| Novo Nordisk Inc | 9 | $136 |
| AstraZeneca Pharmaceuticals LP | 7 | $107 |
| PFIZER INC. | 5 | $99 |
| Abbott Laboratories | 3 | $70 |
| Verona Pharma, Inc. | 2 | $52 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $44 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
Products named: MOUNJARO, VRAYLAR, JARDIANCE, AIRSUPRA, PREVNAR 20, Rybelsus, Ohtuvayre, REXULTI.
Industry payments across PA — which companies pay providers there.
